These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32452698)

  • 21. Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
    Jiang Z; Yin J
    J Surg Oncol; 2020 Jun; 121(8):1181-1190. PubMed ID: 32167588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
    Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions.
    Cao Y; Huang Y; Chen X; Wang W; Chen H; Yin T; Nickel D; Li C; Shao J; Zhang S; Wang X; Zhang J
    Insights Imaging; 2024 May; 15(1):112. PubMed ID: 38713334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging.
    Sagawa H; Kataoka M; Kanao S; Onishi N; Nickel MD; Toi M; Togashi K
    Magn Reson Med Sci; 2019 Jul; 18(3):200-207. PubMed ID: 30416179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?
    Kataoka M; Honda M; Ohashi A; Yamaguchi K; Mori N; Goto M; Fujioka T; Mori M; Kato Y; Satake H; Iima M; Kubota K
    Magn Reson Med Sci; 2022 Mar; 21(1):83-94. PubMed ID: 35228489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
    El Khouli RH; Macura KJ; Jacobs MA; Khalil TH; Kamel IR; Dwyer A; Bluemke DA
    AJR Am J Roentgenol; 2009 Oct; 193(4):W295-300. PubMed ID: 19770298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
    Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
    Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
    Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
    Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
    Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
    Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity.
    Heacock L; Gao Y; Heller SL; Melsaether AN; Babb JS; Block TK; Otazo R; Kim SG; Moy L
    J Magn Reson Imaging; 2017 Jun; 45(6):1746-1752. PubMed ID: 27859874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
    Kim SY; Cho N; Choi Y; Shin SU; Kim ES; Lee SH; Chang JM; Moon WK
    Korean J Radiol; 2020 May; 21(5):561-571. PubMed ID: 32323501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive ability of DWI/ADC and DCE-MRI kinetic parameters in differentiating benign from malignant breast lesions and in building a prediction model.
    Allarakha A; Gao Y; Jiang H; Wang GL; Wang PJ
    Discov Med; 2019 Mar; 27(148):139-152. PubMed ID: 31095923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
    Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
    Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
    Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
    J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.